Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine gel vs tetracaine/oxybuprocaine eye drops for needling procedures after glaucoma surgery
2023-505802-40-02Phase 4Authorised
- Sponsor
- Hospital Universitario de Torrevieja
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Glaucoma comparing Ophtesic with COLIROFTA ANESTÉSICO DOBLE (2 arms). Primary endpoints: Patient-reported pain during needling procedure and Average time spent on the procedure. Planned start Feb 2024; status: authorised.
02
Drugs
CU-30101tetracaine + oxybuprocaine
03
Conditions
Glaucoma
Beyond the preview
Go deeper on 2023-505802-40-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505802-40-02.